➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Boehringer Ingelheim
Dow
Express Scripts
Harvard Business School

Last Updated: July 29, 2021

DrugPatentWatch Database Preview

Clindamycin phosphate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic sources for clindamycin phosphate and what is the scope of freedom to operate?

Clindamycin phosphate is the generic ingredient in seventeen branded drugs marketed by Perrigo Uk Finco, Taro Pharm Inds Ltd, Mylan, Pfizer, Fougera Pharms, Perrigo Pharma Intl, Bausch, Encube, Glenmark Pharms Ltd, Solaris Pharma Corp, Taro Pharms, Pharmacia And Upjohn, Abraxis Pharm, Alvogen, Bedford, Bristol Myers Squibb, Fresenius Kabi Usa, Igi Labs Inc, Loch, Marsam Pharms Llc, Mylan Labs Ltd, Sagent Pharms Inc, Solopak, Teva Parenteral, Watson Labs, West-ward Pharms Int, Akorn, Baxter Hlthcare Corp, Sandoz Inc, Abbott Labs, Baxter Hlthcare, Paddock Llc, Boca Pharma Llc, Cadila, Encube Ethicals, Fougera Pharms Inc, G And W Labs Inc, Glasshouse Pharms, Novast Labs, Perrigo New York, Taro Pharm Inds, Teligent, Vintage Pharms, Wockhardt Bio Ag, Perrigo Co, Actavis Mid Atlantic, and Almirall, and is included in seventy-nine NDAs. There are four patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Clindamycin phosphate has seventy-four patent family members in twenty-six countries.

There are fifty-five drug master file entries for clindamycin phosphate. Thirty suppliers are listed for this compound.

Drug Prices for clindamycin phosphate

See drug prices for clindamycin phosphate

Recent Clinical Trials for clindamycin phosphate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Memorial Sloan Kettering Cancer CenterPhase 2
Daré Bioscience, Inc.Phase 3
Gage Development Company, LLCPhase 3

See all clindamycin phosphate clinical trials

Pharmacology for clindamycin phosphate
Paragraph IV (Patent) Challenges for CLINDAMYCIN PHOSPHATE
Tradename Dosage Ingredient NDA Submissiondate
CLINDESSE CREAM;VAGINAL clindamycin phosphate 050793 2015-02-05
EVOCLIN AEROSOL, FOAM;TOPICAL clindamycin phosphate 050801

US Patents and Regulatory Information for clindamycin phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer CLEOCIN clindamycin phosphate CREAM;VAGINAL 050680-001 Aug 11, 1992 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Fougera Pharms CLINDAMYCIN PHOSPHATE clindamycin phosphate CREAM;VAGINAL 065139-001 Dec 27, 2004 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Taro Pharm Inds Ltd CLINDAMYCIN PHOSPHATE clindamycin phosphate AEROSOL, FOAM;TOPICAL 210004-001 Mar 11, 2020 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Baxter Hlthcare CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER clindamycin phosphate INJECTABLE;INJECTION 050648-002 Dec 29, 1989 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Baxter Hlthcare CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER clindamycin phosphate INJECTABLE;INJECTION 050648-001 Dec 29, 1989 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Bristol Myers Squibb CLINDAMYCIN PHOSPHATE clindamycin phosphate INJECTABLE;INJECTION 062908-001 Feb 1, 1989 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Actavis Mid Atlantic CLINDAMYCIN PHOSPHATE AND TRETINOIN clindamycin phosphate; tretinoin GEL;TOPICAL 202564-001 Jun 12, 2015 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for clindamycin phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer CLEOCIN clindamycin phosphate SUPPOSITORY;VAGINAL 050767-001 Aug 13, 1999 ⤷  Try it Free ⤷  Try it Free
Perrigo Pharma Intl CLINDESSE clindamycin phosphate CREAM;VAGINAL 050793-001 Nov 30, 2004 ⤷  Try it Free ⤷  Try it Free
Bausch CLINDAGEL clindamycin phosphate GEL;TOPICAL 050782-001 Nov 27, 2000 ⤷  Try it Free ⤷  Try it Free
Perrigo Pharma Intl CLINDESSE clindamycin phosphate CREAM;VAGINAL 050793-001 Nov 30, 2004 ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for clindamycin phosphate

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1304992 2013/044 Ireland ⤷  Try it Free PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322
1304992 122013000081 Germany ⤷  Try it Free PRODUCT NAME: CLINDAMYCIN (ALS CLINDAMYCIN-PHOSPHAT) UND TRETINOIN; NAT. REGISTRATION NO/DATE: 85210.00.00 20130611; FIRST REGISTRATION: IRLAND PA1332/043/001 20130322
1304992 92401 Luxembourg ⤷  Try it Free PRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE
1304992 SPC/GB13/061 United Kingdom ⤷  Try it Free PRODUCT NAME: CLINDAMYCIN PHOSPHATE IN COMBINATION WITH TRETINOIN.; REGISTERED: IE PA1332/043/001 20130322; UK PL15142/0249 20130624
1304992 C01304992/01 Switzerland ⤷  Try it Free PRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014
1304992 C300617 Netherlands ⤷  Try it Free PRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322
1304992 CR 2013 00053 Denmark ⤷  Try it Free PRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Boehringer Ingelheim
Dow
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.